Delphi Management Inc /Ma/ Jazz Pharmaceuticals PLC Transaction History

Delphi Management Inc /Ma/

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 21, 2024	SELL	$115.19 - $132.77 $60,705 - $69,969	-527 Reduced 4.83%	10,374 $1.25 Million
Q4 2023 May 20, 2024	BUY	$114.26 - $136.0 $79,410 - $94,520	695 Added 6.81%	10,901 $1.34 Million
Q3 2023 Jan 25, 2024	BUY	$122.0 - $145.31 $1,464 - $1,743	12 Added 0.12%	10,206 $1.32 Million
Q2 2023 Aug 28, 2023	BUY	$122.5 - $147.16 $183,382 - $220,298	1,497 Added 17.21%	10,194 $1.26 Million
Q4 2022 Jul 11, 2023	BUY	$129.72 - $159.85 $414,455 - $510,720	3,195 Added 58.07%	8,697 $1.39 Million
Q4 2021 Feb 15, 2022	SELL	$119.87 - $145.67 $115,674 - $140,571	-965 Reduced 14.92%	5,502 $701,000
Q3 2021 Nov 15, 2021	SELL	$128.64 - $184.79 $91,077 - $130,831	-708 Reduced 9.87%	6,467 $842,000
Q2 2021 Aug 16, 2021	SELL	$160.2 - $186.42 $7,369 - $8,575	-46 Reduced 0.64%	7,175 $1.28 Million
Q1 2021 May 14, 2021	BUY	$150.19 - $173.5 $1.08 Million - $1.25 Million	7,221 New	7,221 $1.19 Million

490

57M

155K

152K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $6.86B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Delphi Management Inc /Ma/, based on Form 13F filings with the SEC.

Stay updated on Delphi Management Inc /Ma/ with notifications on news.